ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Pembrolizumab and Ipilimumab as Second-Line Therapy for Advanced Melanoma.

Laura A Huppert et al.PubMed ↗Publisher ↗

No numbers read from the abstract.